1241752-31-7 Usage
General Description
5-bromo-2-ethoxy-3-methoxypyridine is an organic compound with the molecular formula C8H10BrNO2. It is a pyridine derivative with a bromine atom at the 5-position, an ethoxy group at the 2-position, and a methoxy group at the 3-position. 5-bromo-2-ethoxy-3-methoxypyridine is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable intermediate in the production of various biologically active compounds. It is also used in research laboratories as a starting material for the synthesis of more complex molecules. Overall, 5-bromo-2-ethoxy-3-methoxypyridine has diverse applications in the field of organic chemistry and drug discovery.
Check Digit Verification of cas no
The CAS Registry Mumber 1241752-31-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,4,1,7,5 and 2 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1241752-31:
(9*1)+(8*2)+(7*4)+(6*1)+(5*7)+(4*5)+(3*2)+(2*3)+(1*1)=127
127 % 10 = 7
So 1241752-31-7 is a valid CAS Registry Number.
1241752-31-7Relevant articles and documents
COMPOUNDS AND USES THEREOF
-
Page/Page column 256, (2018/05/17)
The present invention features compounds useful in the treatment of neurological disorders. The compounds of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing neurological disorders.
ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
-
Page/Page column 53-54, (2011/08/04)
The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS
-
Page/Page column 52, (2010/12/18)
The present invention relates to compounds useful as inhibitors of P13K, particularly of P13Kgamma. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of several diseases, such as cancer and autoimmune diseases.
